$CMRX
CHIMERIX INC Stock $cmrx

$cmrx Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000111748020000022 Filed on May 07, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$1.241M	$2.356M
YoY Change	-47.33%	198.23%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.210M	$7.690M
YoY Change	-58.26%	14.09%
% of Gross Profit
Research & Development	$8.949M	$13.52M
YoY Change	-33.78%	-5.88%
% of Gross Profit
Depreciation & Amortization	$112.0K	$149.0K
YoY Change	-24.83%	-39.92%
% of Gross Profit
Operating Expenses	$12.15M	$21.20M
YoY Change	-42.67%	0.49%
Operating Profit	-$10.91M	-$18.85M
YoY Change	-42.09%	-7.2%
Interest Expense	$490.0K	$1.160M
YoY Change	-57.76%	87.1%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$10.42M	-$17.69M
YoY Change	-41.1%	-10.79%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$10.42M	-$17.69M
YoY Change	-41.11%	-10.76%
Net Earnings / Revenue	-839.65%	-750.98%
Basic Earnings Per Share	-$0.17
Diluted Earnings Per Share	-$0.17	-$347.6K
COMMON SHARES
Basic Shares Outstanding	61.74M shares	50.90M shares
Diluted Shares Outstanding	61.74M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$103.0M	$171.6M
YoY Change	-39.98%	6.98%
Cash & Equivalents	$24.55M	$19.71M
Short-Term Investments	$78.50M	$151.9M
Other Short-Term Assets	$2.600M	$2.500M
YoY Change	4.0%	-19.35%
Inventory
Prepaid Expenses
Receivables	$1.079M	$1.425M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$106.7M	$175.5M
YoY Change	-39.2%	7.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$435.0K	$1.158M
YoY Change	-62.44%	-31.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$16.00K	$53.00K
YoY Change	-69.81%	-13.11%
Total Long-Term Assets	$1.029M	$2.443M
YoY Change	-57.88%	-95.21%
TOTAL ASSETS
Total Short-Term Assets	$106.7M	$175.5M
Total Long-Term Assets	$1.029M	$2.443M
Total Assets	$107.8M	$178.0M
YoY Change	-39.45%	-17.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.124M	$2.492M
YoY Change	-54.9%	31.71%
Accrued Expenses	$5.556M	$10.39M
YoY Change	-46.52%	46.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.680M	$12.88M
YoY Change	-48.14%	43.11%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$800.0K
YoY Change	-100.0%	300.0%
Total Long-Term Liabilities	$0.00	$800.0K
YoY Change	-100.0%	300.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.680M	$12.88M
Total Long-Term Liabilities	$0.00	$800.0K
Total Liabilities	$6.728M	$13.68M
YoY Change	-50.82%	48.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$679.3M	-$574.0M
YoY Change	18.35%	13.29%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$101.0M	$164.3M
YoY Change
Total Liabilities & Shareholders Equity	$107.8M	$178.0M
YoY Change	-39.45%	-17.18%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$10.42M	-$17.69M
YoY Change	-41.11%	-10.76%
Depreciation, Depletion And Amortization	$112.0K	$149.0K
YoY Change	-24.83%	-39.92%
Cash From Operating Activities	-$10.82M	-$15.73M
YoY Change	-31.23%	-15.01%
INVESTING ACTIVITIES
Capital Expenditures	$7.000K	$97.00K
YoY Change	-92.78%	130.95%
Acquisitions
YoY Change
Other Investing Activities	$18.25M	-$45.73M
YoY Change	-139.91%	-308.05%
Cash From Investing Activities	$18.24M	-$45.83M
YoY Change	-139.81%	-308.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$229.0K	$160.0K
YoY Change	43.13%	15.94%
NET CHANGE
Cash From Operating Activities	-$10.82M	-$15.73M
Cash From Investing Activities	$18.24M	-$45.83M
Cash From Financing Activities	$229.0K	$160.0K
Net Change In Cash	$7.652M	-$61.40M
YoY Change	-112.46%	-1822.81%
FREE CASH FLOW
Cash From Operating Activities	-$10.82M	-$15.73M
Capital Expenditures	$7.000K	$97.00K
Free Cash Flow	-$10.83M	-$15.83M
YoY Change	-31.61%	-14.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q4	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	1868000	USD
CY2020Q1	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	2612000	USD
CY2020Q1	cmrx	Availableforsale Securities Debt Maturities Year Two Fair Value AvailableforsaleSecuritiesDebtMaturitiesYearTwoFairValue	0	USD
CY2019	cmrx	Fixed Asset Disposals FixedAssetDisposals	300000	USD
CY2019	cmrx	Fixed Asset Disposals FixedAssetDisposals	250000	USD
CY2019Q4	cmrx	Lease Liability Noncurrent LeaseLiabilityNoncurrent	196000	USD
CY2020Q1	cmrx	Lease Liability Noncurrent LeaseLiabilityNoncurrent	48000	USD
CY2020Q1	cmrx	Lessee Operating Sublease Areaof Sublease Property LesseeOperatingSubleaseAreaofSubleaseProperty	3537	sqft
CY2020Q1	cmrx	Numberof Product Candidates NumberofProductCandidates	2	product_candidate
CY2019Q1	cmrx	Operating Lease Rightof Use Asset Amortization OperatingLeaseRightofUseAssetAmortization	-16000	USD
CY2020Q1	cmrx	Operating Lease Rightof Use Asset Amortization OperatingLeaseRightofUseAssetAmortization	-21000	USD
CY2019	cmrx	Restructuring Reserve Accruals RestructuringReserveAccruals	5781000	USD
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001117480
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	61930339	shares
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	CHIMERIX INC
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2398000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1124000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1233000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1079000	USD
CY2019Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	595000	USD
CY2020Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	191000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6830000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5556000	USD
CY2019Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	3626000	USD
CY2020Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	1734000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	35000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	778693000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	780248000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4073000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1326000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4073000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1326000	USD
CY2019Q4	us-gaap	Assets Assets	119376000	USD
CY2020Q1	us-gaap	Assets Assets	107769000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	118093000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	106740000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	50000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	76000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	15000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	90000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	96539000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	78483000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	78469000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	96574000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	78469000	USD
CY2019	us-gaap	Business Exit Costs1 BusinessExitCosts1	2021000	USD
CY2019	us-gaap	Business Exit Costs1 BusinessExitCosts1	2000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81106000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19705000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16901000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24553000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-61401000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7652000	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61590013	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61930339	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61590013	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61930339	shares
CY2019Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	62000	USD
CY2020Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	62000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17553000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10466000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	security
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	security
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	22798000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	30880000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	15000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	90000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	9	security
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	14	security
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	22798000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	30880000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	15000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	90000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	9	security
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	14	security
CY2019Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent	96574000	USD
CY2020Q1	us-gaap	Debt Securities Current DebtSecuritiesCurrent	78469000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	149000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	112000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2019Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-8000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7686000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3205000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-624000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2542000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1095000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-154000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-59000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-762000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1152000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	493000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	901000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	723000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	182000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	182000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	719000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	541000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	66000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	42000	USD
CY2020Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	75000	USD
CY2020Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	61000	USD
CY2020Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	14000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	9424000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	6728000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119376000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	107769000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9228000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6680000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	160000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	229000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45827000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	18243000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15734000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10820000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-17693000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-10420000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	21201000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	12154000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-18845000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10913000	USD
CY2019Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	194000	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	193000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	835000	USD
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	681000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	633000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	48000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	192000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	178000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	709000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	578000	USD
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1307
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y11D
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1336000	USD
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1210000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	140000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-46000	USD
CY2019	us-gaap	Other Restructuring Costs OtherRestructuringCosts	300000	USD
CY2019	us-gaap	Other Restructuring Costs OtherRestructuringCosts	339000	USD
CY2019	us-gaap	Payments For Restructuring PaymentsForRestructuring	5125000	USD
CY2020Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	218000	USD
CY2019Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	23000	USD
CY2020Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	97000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000	USD
CY2019Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	69680000	USD
CY2020Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	27652000	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2020Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3385000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2639000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	170000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	229000	USD
CY2019Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	23950000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	45902000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-17693000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-10420000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	540000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	435000	USD
CY2019Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	13515000	USD
CY2020Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	8949000	USD
CY2019Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	43	employee
CY2019	us-gaap	Restructuring Charges RestructuringCharges	5956000	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	320000	USD
CY2020Q1	us-gaap	Restructuring Reserve RestructuringReserve	88000	USD
CY2019	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-336000	USD
CY2020Q1	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-14000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-668838000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2356000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1241000	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	3300000	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	3346000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4073000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1326000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	1800000	USD
CY2019Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	168000	shares
CY2020Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	163000	shares
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	170000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-679258000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	229000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	177604000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	164307000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	109952000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	101041000	USD
CY2019Q1	us-gaap	Sublease Income SubleaseIncome	18000	USD
CY2020Q1	us-gaap	Sublease Income SubleaseIncome	18000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	50887221	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	61742035	shares
CY2020Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net income or stockholders' equity (deficit).</font></div></div>

Files In Submission

Name	View Source	Status
0001117480-20-000022-index-headers.html	Edgar Link	pending
0001117480-20-000022-index.html	Edgar Link	pending
0001117480-20-000022.txt	Edgar Link	pending
0001117480-20-000022-xbrl.zip	Edgar Link	pending
a20200331cmrx10-qdocument.htm	Edgar Link	pending
a20200331cmrxex-311.htm	Edgar Link	pending
a20200331cmrxex-312.htm	Edgar Link	pending
a20200331cmrxex-321.htm	Edgar Link	pending
a20200331cmrxex-322.htm	Edgar Link	pending
cmrx-20200331.xml	Edgar Link	completed
cmrx-20200331.xsd	Edgar Link	pending
cmrx-20200331_cal.xml	Edgar Link	unprocessable
cmrx-20200331_def.xml	Edgar Link	unprocessable
cmrx-20200331_lab.xml	Edgar Link	unprocessable
cmrx-20200331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMRX
CHIMERIX INC Stock $cmrx

2020 Q1 Form 10-Q Financial Statement

#000111748020000022 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX CHIMERIX INC Stock $cmrx

2020 Q1 Form 10-Q Financial Statement

#000111748020000022 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX
CHIMERIX INC Stock $cmrx